ERA Consulting

ERA Consulting is a premier strategic regulatory affairs and product development consultancy specializing in the biopharmaceutical sector. The firm provides comprehensive support for the development, manufacturing, and registration of complex therapeutics, with a particular focus on biologics, biosimilars, and advanced therapy medicinal products (ATMPs) such as cell and gene therapies. ERA Consulting offers expertise in navigating global regulatory landscapes, including the EMA and FDA, helping clients move from early-stage development through to market authorization. In September 2020, the company was acquired by Lachman Consultant Services, a move that integrated ERA's specialized regulatory knowledge with Lachman's broader compliance and technical expertise. The company maintains a global presence with key offices in Europe and Australia.